Business Context and Reporting Period
Company: Processa Pharmaceuticals, Inc. (PCSA)
Filing Type: Form 8-K (Current Report)
Date of Report: September 2, 2025
Event: Adjournment of Special Shareholder Meeting due to lack of quorum.
Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document is a procedural report regarding a shareholder meeting.
Material Changes
No material financial changes are reported. The primary event is the procedural adjournment of the Special Shareholder Meeting originally scheduled for September 2, 2025, in Pasadena, CA, because a quorum was not present.
Outlook, Management Commentary, and Risks
- Meeting Reschedule: The Special Shareholder Meeting will reconvene on September 12, 2025, at 5:00 PM ET in Vero Beach, FL.
- Voting Eligibility: The record date remains August 7, 2025. Only stockholders of record as of that date are entitled to vote at the reconvened meeting.
- Proposals: The proposals for the meeting remain unchanged.
- Shareholder Action: Stockholders who have already voted do not need to take further action unless they wish to change their vote.
Key Facts for Investor Verification
- Verify the reconvened meeting date: September 12, 2025.
- Confirm the new meeting location: Vero Beach, FL.
- Check the proxy statement on the SEC website for details on the unchanged proposals.
- Ensure voting eligibility is based on the August 7, 2025 record date.